It will also afford Nutrasource’s clients the opportunity to conduct early-stage clinical studies, including bioavailability and bioequivalence studies
Nutrasource Pharmaceutical and Nutraceutical Services, a global contract research organisation (CRO), has received a Controlled Drugs & Substances Dealer’s licence from Health Canada.
The licence will enable Nutrasource to possess and conduct activities, including, but not limited to holding, distributing, and conducting clinical research studies on controlled substances.
It will also afford Nutrasource’s clients the opportunity to conduct early-stage clinical studies, including bioavailability and bioequivalence studies, proof of concept studies, and efficacy trials with controlled substances in Canada.
“With fully developed study protocols, safe storage and management as well as an experienced QPIC (qualified person in charge) recognised by Health Canada’s Office of Controlled Substances, Nutrasource is ready for controlled drug and substances projects,” said Ana Samborski, Pharmacy Manager, Nutrasource.
William Rowe, Nutrasource President and CEO added: “This licence is an excellent and logical extension of our Institution-Wide Cannabis Research Licence obtained earlier this year. Botanicals and their derivatives continue to be a key focus and these licences enhance our position further in the nutra to pharma services pathway.”